Nu Skin Enterprises, Inc. (NYSE:NUS) Director Pisano R. Thomas sold 15,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, March 7th. The stock was sold at an average price of $72.00, for a total value of $1,080,000.00. Following the transaction, the director now owns 47,437 shares of the company’s stock, valued at $3,415,464. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) opened at $72.37 on Friday. The stock has a market capitalization of $3,797.47, a price-to-earnings ratio of 22.22, a P/E/G ratio of 2.00 and a beta of 1.43. Nu Skin Enterprises, Inc. has a one year low of $48.72 and a one year high of $74.45. The company has a quick ratio of 1.17, a current ratio of 1.74 and a debt-to-equity ratio of 0.44.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 15th. The company reported $1.20 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.19 by $0.01. The business had revenue of $666.20 million during the quarter, compared to the consensus estimate of $667.39 million. Nu Skin Enterprises had a return on equity of 25.23% and a net margin of 5.68%. The firm’s quarterly revenue was up 25.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.79 EPS. equities analysts predict that Nu Skin Enterprises, Inc. will post 3.56 earnings per share for the current fiscal year.
Several research analysts have recently commented on NUS shares. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Deutsche Bank lifted their target price on Nu Skin Enterprises from $75.00 to $77.00 and gave the stock a “buy” rating in a research note on Friday, February 16th. Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 target price for the company in a research note on Saturday, December 30th. Citigroup restated a “buy” rating and issued a $81.00 price target (up from $70.00) on shares of Nu Skin Enterprises in a research note on Tuesday, January 23rd. Finally, Stifel Nicolaus boosted their price target on Nu Skin Enterprises from $50.00 to $57.00 and gave the company a “sell” rating in a research note on Friday, February 16th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. Nu Skin Enterprises has an average rating of “Hold” and a consensus price target of $71.29.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wolverine Asset Management LLC raised its holdings in Nu Skin Enterprises by 106.9% in the 4th quarter. Wolverine Asset Management LLC now owns 1,514 shares of the company’s stock valued at $103,000 after acquiring an additional 23,378 shares in the last quarter. Cerebellum GP LLC acquired a new position in Nu Skin Enterprises in the 4th quarter valued at $124,000. Migdal Insurance & Financial Holdings Ltd. acquired a new position in Nu Skin Enterprises in the 3rd quarter valued at $148,000. Amundi Pioneer Asset Management Inc. acquired a new position in Nu Skin Enterprises in the 4th quarter valued at $192,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Nu Skin Enterprises by 38.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock valued at $210,000 after acquiring an additional 858 shares in the last quarter. Institutional investors and hedge funds own 74.85% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://sportsperspectives.com/2018/03/10/insider-selling-nu-skin-enterprises-inc-nus-director-sells-15000-shares-of-stock.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.